Page last updated: 2024-08-25

chitosan and latanoprost

chitosan has been researched along with latanoprost in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Haniuda, H; Ito, K; Kashiwagi, K; Ohtsubo, S; Takeoka, S1
Chiou, SH; Hsiao, MH; Hung, KH; Larsson, M; Liu, CJ; Liu, DM; Wang, YL1
Cheng, YH; Chiou, SH; Chiu, AW; Hung, KH; Ku, RY; Lee, CJ; Liu, CJ; Tsai, TH1
Cheng, YH; Chien, CS; Chiou, SH; Chiu, AW; Jhan, YY; Liu, CJ; Tsai, KL; Tsai, TH1
Chang, YF; Cheng, YH; Huang, SH; Ko, YC; Liu, CJ1
Castillo, AL; Cubillan, LDP; Macabeo, APG; Rubenicia, AML; Sicam, VADP; Villaflores, OB1

Other Studies

6 other study(ies) available for chitosan and latanoprost

ArticleYear
Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma.
    Investigative ophthalmology & visual science, 2013, Aug-19, Volume: 54, Issue:8

    Topics: Absorbable Implants; Alginates; Animals; Antihypertensive Agents; Aqueous Humor; Behavior, Animal; Chitosan; Cornea; Drug Delivery Systems; Glaucoma; Glucuronic Acid; Hexuronic Acids; Intraocular Pressure; Latanoprost; Nanostructures; Prostaglandins F, Synthetic; Rabbits; Rats; Rats, Sprague-Dawley

2013
A temperature-induced and shear-reversible assembly of latanoprost-loaded amphiphilic chitosan colloids: characterization and in vivo glaucoma treatment.
    Acta biomaterialia, 2014, Volume: 10, Issue:7

    Topics: Aged; Animals; Chitosan; Colloids; Gels; Glaucoma; Humans; Latanoprost; Male; Prostaglandins F, Synthetic; Rabbits; Rheology; Temperature

2014
Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension.
    Acta biomaterialia, 2014, Volume: 10, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Chitosan; Delayed-Action Preparations; Drug Evaluation, Preclinical; Gelatin; Humans; Hydrogels; Latanoprost; Male; Ocular Hypertension; Prostaglandins F, Synthetic; Rabbits; Triamcinolone Acetonide

2014
Thermosensitive chitosan-based hydrogel as a topical ocular drug delivery system of latanoprost for glaucoma treatment.
    Carbohydrate polymers, 2016, Jun-25, Volume: 144

    Topics: Administration, Topical; Animals; Aqueous Humor; Chitosan; Cornea; Drug Carriers; Drug Liberation; Glaucoma; Hydrogels; Intraocular Pressure; Latanoprost; Materials Testing; Prostaglandins F, Synthetic; Rabbits; Temperature

2016
Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment.
    Experimental eye research, 2019, Volume: 179

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Apoptosis; Blotting, Western; Cells, Cultured; Chitosan; Curcumin; Drug Combinations; Drug Delivery Systems; Epithelium, Corneal; Gelatin; Glaucoma; Humans; Hydrogels; Hydrogen Peroxide; In Situ Nick-End Labeling; Latanoprost; Mitochondria; Nanoparticles; Oxidative Stress; Particle Size; Rabbits; Reactive Oxygen Species; Temperature; Trabecular Meshwork

2019
Intraocular Pressure Reduction Effect of 0.005% Latanoprost Eye Drops in a Hyaluronic Acid-Chitosan Nanoparticle Drug Delivery System in Albino Rabbits.
    Translational vision science & technology, 2021, 04-01, Volume: 10, Issue:4

    Topics: Animals; Antihypertensive Agents; Chitosan; Drug Delivery Systems; Hyaluronic Acid; Intraocular Pressure; Latanoprost; Nanoparticles; Ophthalmic Solutions; Prostaglandins F, Synthetic; Rabbits

2021